SEC 13F Intelligence

Managers / Q1 2022 · view latest →

Gagnon Advisors, LLC

CIK 0001599466 · 1370 AVENUE OF THE AMERICAS, 26TH FLOOR, NEW YORK, NY, 10019 · 212-554-5050

Reported Value
$217M
Q1 2022
Positions
33
Filings on Record
32
2019–present window
Filed
May 9, 2022
original filing

Summary

Gagnon Advisors, LLC reported $217M in U.S.-listed holdings across 33 positions for Q1 2022.

Its largest position, PCRX, represents 8.8% of the portfolio.

Compared with Q4 2021, the fund opened 2 new positions and exited 3.

Portfolio Metrics

Turnover
+12.8%
vs prior filed quarter
Top-10 Concentration
+57.6%
share of reported value
Largest Position
+8.8%
Pacira Biosciences Com
New / Exited
2 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $142MQ4 ’18Q1 ’19: $175MQ2 ’19: $175MQ3 ’19: $161MQ4 ’19: $178MQ4 ’19Q1 ’20: $107MQ2 ’20: $139MQ3 ’20: $163MQ4 ’20: $222MQ4 ’20Q1 ’21: $474MQ2 ’21: $263MQ3 ’21: $252MQ4 ’21: $252MQ4 ’21Q1 ’22: $217MQ2 ’22: $165MQ3 ’22: $154MQ4 ’22: $148MQ4 ’22Q1 ’23: $149MQ2 ’23: $149MQ3 ’23: $120MQ4 ’23: $114MQ4 ’23Q1 ’24: $115MQ2 ’24: $131MQ3 ’24: $155MQ4 ’24: $156MQ4 ’24Q1 ’25: $142MQ2 ’25: $149MQ3 ’25: $162MQ4 ’25: $158MQ4 ’25Q1 ’26: $136Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.7%Other: 16.6%MLP: 4.8%REIT: 3.1%ETP: 1.5%Equity WRT: 0.3%
  • Common Stock · 73.7% · $160M
  • Other · 16.6% · $36M
  • MLP · 4.8% · $10M
  • REIT · 3.1% · $7M
  • ETP · 1.5% · $3M
  • Equity WRT · 0.3% · $736,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
EVAUSDENVIVA INCNEW+159.3K159.3K+$13M$13M
DIREXION SHS ETF TRNEW+46.1K46.1K+$3M$3M
EVAUSDENVIVA PARTNERS LPSOLD OUT−144.8K0−$10M$0
CSLT1EURCASTLIGHT HEALTH INCSOLD OUT−2.96M0−$5M$0
SMFRUSDSEMA4 HOLDINGS CORPADDED+739.1K1.48M+$1M$5M
MIROMATRIX MED INCADDED+229.8K459.6K+$742,000$2M
AMERICAN WELL CORPSOLD OUT−4.6K0−$64,000$0
EPDENTERPRISE PRODS PARTNERS L PADDED+123.9K399.9K+$4M$10M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2022

30 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1PCRXPACIRA BIOSCIENCES COMhistory →COM8.83%$19M251.1K
2AMRCAMERESCO INChistory →CL A6.60%$14M180.3K
3ALAIR LEASE CORPhistory →CL A6.27%$14M305.0K
4NAVIGATOR HOLDINGS LTDSHS6.15%$13M1.09M
5EVAUSDENVIVA INChistory →COM UNIT5.81%$13M159.3K
6ALPHA AND OMEGA SEMICONDUCTORSHS5.68%$12M225.4K
7EPDENTERPRISE PRODS PARTNERS L Phistory →COM4.75%$10M399.9K
8CDNACAREDX INChistory →COM4.73%$10M277.3K
9FIVNFIVE9 INChistory →COM4.55%$10M89.4K
10NEWREURNEW RELIC INChistory →COM4.22%$9M137.0K
11BLBLACKLINE INChistory →COM4.18%$9M123.8K
12HQ8FAPOLLO ENDOSURGERY INChistory →COM3.71%$8M1.33M
13ETWOGBPE2OPEN PARENT HOLDINGS INCCOM CL A · W EXP 2/04/2023.67%$8M1.12M
14EQIXEQUINIX INChistory →COM3.13%$7M9.2K
1507SSECUREWORKS CORPhistory →CL A2.86%$6M468.6K
16LUMBER LIQUIDATORS HOLDINGS INCCOM2.65%$6M409.8K
17YEXTYEXT INChistory →CL A2.58%$6M812.5K
18ZUOUSDZUORA INChistory →CL A2.34%$5M339.8K
19SMFRUSDSEMA4 HOLDINGS CORPCOM CL A · W EXP 07/22/20262.17%$5M1.72M
20BLFSBIOLIFE SOLUTIONS INChistory →COM NEW2.16%$5M206.0K
21EVBGEUREVERBRIDGE INChistory →COM2.10%$5M104.4K
22SOMALOGIC INCCLASS A COM · W EXP 8/31/20261.99%$4M615.6K
23PRNPROFOUND MED CORPhistory →COM NEW1.83%$4M441.1K
24DIREXION SHS ETF TR20YR TRES BEAR1.52%$3M46.1K
25CNFINANCE HLDGS LTDSPON ADS1.16%$3M784.0K
26FRSHFRESHWORKS INCCLASS A COM0.98%$2M118.6K
27PSIXPOWER SOLUTIONS INTERNATIONAL INCCOM0.90%$2M626.6K
28OPSEUROPSENS INCCOM0.84%$2M1.20M
29MIROMATRIX MED INCCOM0.84%$2M459.6K
30CELCCELCUITY INCCOM0.81%$2M187.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$136M22Apr 22, 202613F-HRchanges · EDGAR ↗
Q4 2025$158M23Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$162M24Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$149M24Jul 23, 202513F-HRchanges · EDGAR ↗
Q1 2025$142M28May 12, 202513F-HRchanges · EDGAR ↗
Q4 2024$156M26Jan 24, 202513F-HRchanges · EDGAR ↗
Q3 2024$155M27Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$131M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$115M27May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$114M26Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$120M28Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$149M29Aug 8, 202313F-HRchanges · EDGAR ↗
Q1 2023$149M28Apr 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$148M29Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$154M32Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$165M33Aug 1, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M33May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$252M34Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$252M35Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$263M32Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$474M30May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$222M29Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$163M30Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$139M26Aug 14, 2020RESTATEMENTchanges · EDGAR ↗
Q1 2020$107M27May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$178M32Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$161M32Nov 8, 201913F-HRchanges · EDGAR ↗
Q2 2019$175M33Aug 12, 201913F-HRchanges · EDGAR ↗
Q1 2019$175M33May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$142M31Jan 18, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.